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H I G H M O L E C U L A R T H Y R O T R O P H I N ( " B I G " - T S H ) 
F R O M H U M A N P I T U I T A R I E S : P R E P A R A T I O N A N D P A R T I A L 
C H A R A C T E R I Z A T I O N 
By 
Friedrich W. ErhardI and Peter C. Scriba 
A B S T R A C T 
Homogenates of human pituitaries were centrifuged at 30 000 x g and the 
supernatant chromatographed on Scphadex G-100. Approximately 1 % of 
the radioimmunologically measured total activity of T S H was eluted in 
the void volume. Rechromatography of this material on Sephadex G-200 
usually showed TSH-activity at K a v = 0.5 (regular TSH), K a v = 0 (void 
volume-TSH) and at K a v = 0.3 ("big"-TSH). "Big"-TSH was extracted 
from the corresponding fractions by ai finity-chromatography with solid 
phase anti-TSH. It was eluted with 5 mol/1 ammonium thiocyanate and 
further characterized: 
1. The molecular weight was approximately 200 000 by comparison with 
bovine catalase on Sephadex G-200. 
2. Immunoidentity as compared with standard-TSH (M. R. C. 68/38) was 
shown by parallel dilution curves in the radioimmunoassay. 
3. Concanavalin-A-Sepharose adsorbed "big"-TSH, which could be 
eluted with a-methyl-D-mannoside, indicating the glycoprotein nature 
of "big"-TSH. 
4. On polyacrylamide-gel-electrophoresis pH 7.5, "big"-TSH migrated 
faster (/?/(- = 0.32) than regular T S H (Rp> = 0.1), indicating a more nega-
tively charged molecule. 
5. "Big"-TSH, in contrast to regular TSH, was remarkably stable against 
6 mol/1 guanidine hydrochloride, suggesting a covalently linked (aggre-
gate) structure. 
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6. I °/o mercaptoethanol destroyed the immunological activity of both 
regular and "big"-TSH. 
7. "Big'-TSH was digested by trypsin, under mild conditions, to radio-
immunologically active products with molecular weights between "big"-
and regular TSH, but practically no regular T S H was formed. 
8. "Big"-TSH and guanidine-treated "big"-TSH, as well as regular 
TSH and T S H from the void volume of Sephadex G-200 columns, ex-
hibited biological activity in a cytochemical bioassay in good agreement 
with the respective immunological activities. 
High molecular forms of Proteohormones known as "big"-hormones have been 
described for several years as reviewed by Yalow (1974). Recently, "big"-
hormones were also observed in the field of pituitary glycoprotein hormones: 
"big"-LH {Prentice 8c Ryan 1975; Graessltn et cd. 1976) "big"-TSH (Erhardt 
1975; Erhardt 8c Scriba 1976) and "big"-/?-TSH (GoUtein-Golaire 8c Vanhaelst 
1975; Kourides et al. 1976). There is still little known about the chemical 
structure and biological significance of the high molecular species of glyco-
protein hormones. 
M A T E R I A L S A N D M E T H O D S 
Reagents 
Rabbit IgG for coprecipitation in the radioimmunoassays: bovine catalase, equine 
ferritin for the calibration of Sephadex columns; materials for polyacrylamide-gel-
electrophoresis (PAGE): Acrylamide, tetramethylethylenediamine, N,N-methylcnebis-
acrylamide and ammonium persulphate; Triton X 100; a-methyl-D-mannoside; trypsin 
(less than 0.24 % chymotrypsin) and trypsin inhibitor from lima bean were obtained 
from Serva GmbH (Heidelberg, Germany). 
All Sephadex gels (G-75; G-100; G-200; OAE-A-50: Cl-Sepharose 2 B; Con A-
Sepharose) were obtained from Pharmacia Fine Chemicals (Uppsala, Sweden), and 
sodium phosphate, sodium chloride, sodium EDTA, sodium azide. ammonium thio-
cyanate, and guanidinc (mostly analytical grade), from Merck AG (Darmstadt, Ger-
many). Bovine albumin (Pentex®) was purchased from Roth (Munich, Germany). TSH 
for labelling and anti-TSH for radioimmunoassay were kindly donated by the NIAMDD 
(Bethesda, Maryland). Anti-TSH for affinity-chromatography was donated by Farb-
werke Hoechst A G (Frankfurt, Germany). Sodium ^iodide for labelling was also ob-
tained from Hoechst AG. Anti-TSH-serum for affinity chromatography was also pro-
duced in our laboratories by immunization of two rabbits with TSH (4 U/mg) pur-
chased from Deutsche Kabi GmbH (Munich, Germany). HCG, Primogonyl® for ab-
sorption in the radioimmunoassay of T S H and for immunization of rabbits, was ob-
tained from Schering A G (W-Berlin, Germany). Anti-rabbit precipitating scrum (don-
key) was obtained from Wellcome Ltd. (England). "Eppendorf" plastic tubes (vol. 
1.5 ml) for all radioimmunoassays were purchased from Nethcler & Hinz (Hamburg, 
Germany). Human pituitaries obtained at autopsy, usually performed 24-36 h after 
exitus, were kept frozen at -28°C. Pituitaries kept in acetone were also used. 
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Buffers 
A: 0.015 mol/1 sodium phosphate; 0.15 mol/1 sodium chloride; 0.2% bovine-albumin; 
0.002 % sodium azidc; 0.02 mol/1 EDTA, pH 7.4. 
B: As buffer A, with 4.2 % bovine albumin and no E D T A . 
G: As buffer A, but without albumin and E D T A . 
D: 0.1 mol/1 sodium phosphate, pH 6.5. 
E : 0.5 ml/1 sodium carbonate, pH 8.6. 
F: As buffer E , but with 2 mol/1 sodium chloride, pH 8.6. 
G: 0.1 mol/l sodium carbonate; 2 mol/1 sodium chloride, pH 8.6. 
H : 0.1 mol/1 sodium acetate; 2 mol/1 sodium chloride, pH 4.5. 
I: 0.01 mol/1 Tris, pH 7.5. 
Radioimmunoassays of IiTSH, hLH and hGH 
Radioimmunoassays were carried out using the double antibody technique and a 
modular analyzer system {Marschner et cd. 1975), RIA-E-6000 laboratorium Prof. Ber-
thold (Karlsruhe, Germany) and Ismatec (Zürich, Switzerland). All hormones were 
labelled with by slight modification of the chloramine-T-method {Greenwood et cd. 
1963). H T S H was measured with minor modifications as described previously {Erhardt 
et al. 1973) using the international standard M. R. C. 68/38 (NIMR, Mill Hill, London). 
H L H was measured using anti-HCG from rabbits from our laboratory, L H for label-
ling was purchased from Calbiochem (California, USA), and standard L. E. R. 907 ob-
tained from NIAMDD. H G H was measured using rabbit anti-HGH from our labora-
tory, H G H "reinst" for labelling and "creschormone" for standards from Deutsche Kabi 
GmbH (Munich, Germany). 
Preparation of "big"-TSH 
4-50 pituitaries were thawed at 4°C and homogenized in 5-30 ml cold buffer C 
for 1 min in a Vortex homogenizer at low speed and for 1 min at high speed. The 
temperature was allowed to rise to 27°C. The homogenate was centrifuged for 30 min 
at 30 000 x g at 4°C in a Beckmann ultracentrifuge type L-40. The red-brown and still 
turbid supernatant was chromatographed on a Sephex G-100 glass column (3 x 130 cm) 
with buffer C under hydrostatic pressure (flow rate 10-15 ml/h). Fractions from 3-6 ml 
were collected in glass tubes using fraction collector Linear I I , Serva GmbH (Heidel-
berg, Germany). The hormone activities, TSH, L H and H G H were measured in each 
fraction in adequate dilutions (10°—105) in buffer B. Crude "big"-TSH was eluted con-
stantly in the turbid fractions of the void volume (K.|V = 0) and was usually measured 
in 1 to 100 n\ of the eluates (Fig. 1). 
For further purification the "big"-TSH containing fractions were concentrated to a 
volume of 2-5 ml by ultrafiltration at 4°C, using collodion bags, obtained by Sartorius 
A G (Göttingen, Germany). 
After centrifugation at 30 000 x g for 30 min, the turbid concentrate was re-chroma-
tographed on Sephadex G-200 under hydrostatic pressure. The columns were previously 
coated with 20 ml buffer B and were equilibrated over-night at 4°C with elution 
buffer C: 3-6 ml fractions were collected (Fig. 2). 
Immunization of rabbits 
TSH-antiserum was raised in 2 rabbits, which were each immunized by 4 injections, 
beginning with 100 ug subcutaneously followed by 3 injections of 50 ug TSH, all in 
incomplete Freund's adjuvant. After eight weeks one rabbit showed 50% binding of 
[ 1 2 5 1 ] T S H in a final dilution of 1:100 000. 
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Preparation of the anti-TSH-affinity gel 
Activation of Cl-Sepharose-2 B by cyanogen bromide purchased from Merck A G 
(Darmstadt, Germany) was performed according to the instructions of Pharmacia Fine 
Chemicals. Ten g of the wet gel cake was suspended in 30 ml buffer E and reacted 
with 4 g cyanogen bromide, dissolved in 20 ml of distilled water. Under continuous 
control by a glass-electrode and under magnetic stirring, the pH of the mixture was 
kept between pH 10 and 11 by dropwise addition of 20 °/o sodium hydroxide. The 
temperature was kept below 30°C by addition of ice. After 20 min the reaction mixture 
was filtered through a sintered glass funnel and washed with 500 ml of 0.1 mol/1 
sodium carbonate, pH 8.6. 
Binding of anti-TSH-IgG 
The preparation of IgG was performed using the ion exchange gel OAE-A-50-
Sepharose according to the instructions of Pharmacia Fine Chemicals, elution was with 
buffer D, and concentration by ultrafiltration. Five mg of the IgG dissolved in 10 ml 
buffer F was added to 1 g of the wet, freshly prepared activated Cl-Sepharose-2 B-cake 
in a polystyrene-beaker and slowly rotated at room temperature for 3 h continued 
over-night at 4°C. The mixture was again filtered over a sintered glass funnel. The 
optical density of the filtrate at 280 nm was measured and compared with the light 
absorption before extraction with the activated gel to calculate roughly the proportion 
of protein linked to the gel. This varied between 40-90 % (2-4.5 mg protein/g wet 
Sepharose). 
To inactivate the anti-TSH gel it was suspended in 20 ml of 1 mol/1 glycine and 
rotated for 3 h at room temperature. After filtration, the affinity gel was repeatedly 
and alternately washed 10 times with buffer G and buffer H (50 ml each). 
p\J TSH/ml 
30 34 38 42 46 50 54 58 62 6(5 ' 70 ' 74 ' 78 ' 82 ' 86 ' 90 ' 94 ' 98 ' 102' 
4.9 ml F r a c t i o n s 
Fig. J. 
Chromatogram of the 30 000 g supernatant of 4 human pituitaries on Sephadex G-100 
(134x3 cm; buffer C; 4°C). 
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p U T S H / m l 
32 36 40 44 48 52 56 60 64 68 72 
3 ml F R A C T I O N S 
Fig. 2. 
Chromatograms of "big"-TSH on Sephadex G-200 before and after mild 
tryptic digestion. (130 x 1.7 cm; buffer C; 4°C). 
0 Grude product from Sephadex G-100, showing void volume T S H (I); 
"big"-TSH (II) and regular TSH (III). 
• Untreated "big"-TSH, re-chromatographed. 
O 5 m i n treated with trypsin. 
^ 10 min treated with trypsin. 
Specific extraction of "big"-TSH from Sephadex eluates 
One g of wet, freshly prepared affinity-gel was added to the pooled "big"-TSH 
fractions from the Sephadex chromatography (20-80 ml). After slow rotation at room 
temperature for 2 h the gel was filtered (Schott AG, Fritte 1 G 2) and again repeatedly 
washed (at least 4 times), alternating between buffer G and buffer H in order to 
remove physically adsorbed proteins. 
Elution of "big"-TSH from the affinity-gel 
The wet affinity-gel cake loaded with "big"-TSH was suspended in buffer C and 
poured into a small column (10 ml plastic syringe with filter). 'Big"-TSH was eluted 
with 20 ml of freshly prepared 5 mol/1 ammonium thiocyanate in distilled water, pH 7, 
within 10-20 min and collected in dialysis tubing. Dialysis against 6 1 distilled water 
was carried out over 24 h at 4°C with a single change of the outer fluid. The dialyzed 
"big"-TSH was subsequently concentrated by ultrafiltration through collodion bags to 
give a final volume of 0.5-1 ml. HTSH, H G H and H L H activity were determined 
by radioimmunoassay and the protein concentration by lightabsorption at 280 nm 
(0.7 O. D..^ o ^ I mg protein/ml) to monitor the purification. The product was re-chro-
matographed on Sephadex G-200 and the fractions collected either in siliconized glass 
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tubes, or with 0.2 ml of buffer B in the bottom of the tubes, in order to reduce adsorp-
tion onto the glass. Concentration was again performed by ultrafiltration in collodion 
bags. 
Polyacrylamide-gel-eleclrophoresis (PAGE) 
PAGE was performed in 0.5 mol/1 Tris-HCl at p H7.5 (Smith 1968). Bromphenolblue 
was used as a marker. Two hundred uU of "big"-TSH or TSH, respectively, was ap-
plied to the columns (separation gel: 7 x 0.5 cm, concentration gel 2 x 0.5 cm). At the 
end of the electrophoresis, the gels were frozen at -80°C for 30 min and subsequently 
cut into 45 slices of 1.5 mm using razor-blades. The slices were each placed in 0.6 ml 
of buffer B and allowed to elute (for 20 h) at room temperature. The TSH-activity in 
the eluate from each slice was measured by radioimmunoassay (Fig. 5). 
Treatment of "big"-TSH and regular TSH with guanidine and 
Triton X 100 
Triton X 100 (0.25 %) and guanidine-HCl (6 mol/1 final concentration) were dis-
solved in 2 ml of "big"-TSH-solution in buffer A (pH 5.1), and the mixture incubated 
for 1 h at 37°C. For comparison, incubations were also performed without guanidine, 
but with Triton X 100, and without both. The reaction mixtures were chromatographed 
on Sephadex G-100 or G-200, respectively (Fig. 6). 
Mild tryptic digestion of "big"-TSH 
Twenty ag of trypsin in 20 id buffer C was added to 160 //U of "big"-TSH from 
Sephadex G-200 in 200 tu\ of buffer C in a small siliconized glass tube. No calcium was 
added. The solution was incubated at 37°C for 5 or 10 min, respectively, after which 
10 jug of lima bean inhibitor in 20 «1 buffer C was added in order to stop the reaction. 
Re-chromatography was performed on 130x1.7 cm Sephadex G-200, as for the un-
digested "big"-TSH (Fig. 2). 
h-TSHjjU/ml 
70 r 
60 
50 
U 
12 h 
regular 
TSH 
3 RIA (MRC 68/38) 
3 Cytochemtcal Bioassay (MRC Standard A) 
1_ M M 
I I 
"Big"- TSH 
U i 
"Big"-TSH 
treated with 
6 M Guanidin 
TSH trom the 
void Volume 
(Sephadex G200) 
Fie. 
Comparison of the radioimmunologically and cytochemically measured TSH-activity 
of human pituitary TSH-fractions from Sephadex G-200 and of "big"-TSH after 
treatment with 6 mol/1 guanidine-HCl and desalting by re-chromatography. 
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0 0.39 ü'.78 1*56 X 1 3 6 2 5 12.5 25.0 50.0 100 .0 /JU TSH/ml 
Fig. 4. 
Dilution curve of "big"-TSH from affinity chromatography after re-chromatography 
on Sephadex G-200, compared with TSH-standard M. R. C. 68/38. 
£ Dilutions of "big"-TSH. 
Standard curve. 
Mercaptoethanol treatment of "big"-TSH 
Ten u\ mercaptoethanol was added to 160 / Y U "big"-TSH in 1 ml buffer B. For 
comparison, M. R. C. 68/38-TSH was treated identically. After 50 h at 4°C and after 1 h 
at 37°C, aliquots of the reaction mixtures were diluted 1:10 with buffer B to eliminate 
unspecific effects of mercaptoethanol. TSH-activity was then measured by radio-
immunoassay and compared with the activity before treatment. The "big"-TSH was re-
chromatographed on 1.1 x 70 cm Sephadex G-100 (Fig. 7). 
Adsorption of "big"-TSH to Con A-Sepharose 
Two ml of Con A-Sepharose was applied to a 5 ml plastic syringe fitted with a 
glassfilter, and 80 uU of "big"-TSH was added in 0.1 ml of buffer C. The column was 
washed with 8 ml buffer C and the elution subsequently performed with 10 ml 0.05 
mol/1 a-methyl-D-mannoside in buffer C. One ml fractions were collected into Eppen-
dorf vials containing 50 pi\ of buffer B. 
Determination of the DNA-content of "big"-TSH 
Ten mU of "big"-TSH (enriched by affinity chromatography and equivalent to 
approximately 3 ug of regular TSH), dissolved in 0.1 ml of buffer A was treated with 
10 wl (1 mg/ml) proteinase K (Merck AG, Darmstadt, Germany), after dilution with 
0.4 ml buffer I, for 17 h at 37°C, to liberate RNA and DNA from the protein moiety 
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of "big"-TSH. The measurement of DNA and RNA was performed using the sensitive 
fluorescence method with ethidium bromide in the presence of 0.07 mol/1 magnesium 
chloride (Paoletti 8c Le Pecq 1971), and a Perkin-Elmer fluorescence spectrometer 
(MPF-2A). The fluorescence emission was monitored at 586 nm after calibration with 
calf thymus DNA and with unfractionated yeast t-RNA (Boehringer, Mannheim, Ger-
many). The limit of detection for DNA was approximately 0.1 //g/ml and for t-RNA 
1 //g/ml. 
Measurement of the biological activity 
The measurement of the biological activity was performed in the laboratory of Dr. 
von zur Mühlen, Hannover, using the cytochemical bioassay (Bitensky et al. 1974). The 
biological activity was measured in the three main fractions ( K a v = 0, 0.3 and 0.5) of 
pituitary-TSH chromatographed on Sephadex G-200 and likewise in a guanidine-
treated and re-chromatographed "big"-TSH fraction. M. R. C.-TSH-standard A was 
used for calibration. T S H activities of the same fractions were determined in our labo-
ratory in Munich by radioimmunoassay using M. R. C. 68/38 as standard. Comparison 
of standard A and 68/38 in the radioimmunoassay showed standard A to have 85 ± 7 °/o 
of the activity of 68/38-TSH (Fig. 3). 
R E S U L T S 
Chromatography of pituitary supernatants 
Chromatograms of the 30 000 x g supernatants from human pituitary homo-
genates on Sephadex G-100 columns always showed turbid fractions eluting 
in the void volume with TSH-activities of about 1 % of the total T S H - a c -
tivity (Fig. 1). However, re-chromatography on Sephadex G-200 showed that 
these fractions from G-100 were not homogeneous, but were separated into 
TSH-fractions eluting in the void volume of G-200 ( K a v = 0), "big"-TSH-
fractions of K a v 0.3 and regular T S H ( K a v = 0.5) (Figs. 2 and 3). The amount 
of T S H found in the void volume was dependent on the gravity force during 
centrifugation, indicating that in these fractions T S H was still linked to pitui-
tary cell fragments. The further experiments were mainly performed with 
"big"-TSH ( K a v = 0.3). 
Characterization of "big"-TSH 
"Big"-TSH, purified only by re-chromatography on Sephadex G-200 or 
further purified by affinity chromatography, displayed parallelism of its dilu-
tion curves to TSH-standards in the radioimmunoassay (Fig. 4). It was eluted 
on a calibrated Sephadex G-200 column shortly behind bovine catalase (M. W . 
240 000), pointing to a molecular weight of approximately 200 000. The same 
product chromatographed in the polyacrylamide-gel-electrophoresis in Tris-
buffer p H 7.5 migrated with a RF = 0.32 significantly faster than regular 
T S H (Rp = 0.1), indicating "big"-TSH to be a more negatively charged mole-
Acta endocr. S5. 4 
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S L I C E S OF 1.5mm 
Fig. 5. 
Polyacrylamid-gel-electrophoresis of T S H and "big"-TSH. 
A O Regular T S H (NIAMDD HTSH for labelling). 
B 9 "big"-TSH. 
Gel: 7 x 0.5 cm; 0.5 m Tris, pH 7.5; 5-3 mA/column. 
The TSH-activity was measured by radioimmunoassay in 1.5 mm slices after elution 
with buffer B (0.6 ml/slice). 
cule (Fig. 5). Affinity chromatography of "big"-TSH on Con A-Sepharose 
showed that it behaves like a glycoprotein, since it was bound to Con A -
Sepharose like regular T S H . It could also be displaced and eluted by a-
methyl-D-mannoside. 
Measurements of the D N A and R N A content of "big"-TSH, after enrich-
ment by affinity chromatography, using the very sensitive fluorescence method 
with ethidium bromide displayed D N A and R N A content below the limit of 
detection: less than 1.5 % D N A and less than 15 % R N A . 
A l l TSH-fractions (Fig. 3), including those treated with guanidine, dis-
played biological activity. The biological activity of the trypsin-treated frac-
tions have not been measured, because no well defined products were formed. 
Purification and yield of "big"-TSH after preparation by 
affinity chromatography 
Affinity chromatography with solid phase ant i -TSH after prior separation 
of a well defined "big"-TSH fraction by Sephadex chromatography, resulted 
in a 15-40-fold purification as compared with protein or H G H , respectively, 
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Table I. 
Purification and yield of "big"-TSH from 50 pituitaries by affinity chromatography with anti-TSH-Sepharose and Con A-Sepharose after 
prior separation from regular TSH and void volume T S H by one chromatography run on Sephadex G 100 and two subsequent runs on 
Sephadex G 200 (results of one experiment). 
Absolute amounts Purification 
Yield 
"Big"-TSH H L H H G H Protein TSH/HLH T S H - H G H TSH/protein "Big"-TSH 
(°/o) (mU) (U) (mg) (mU/U) (mU//,g) (mU/mg) 
Before affinity 
chromatography 18 47 380 19 0.38 0.047 0.95 100 
In the ammonium 
thiocyanate eluate after 
extraction by anti- 3.1 2.8 4.1 0.18 1.1 0.76 17.2 16.7 
TSH-Sepharose 
In the a-methyl-
not 
measurable 
( < 0.05) 
D-mannoside eluate 
after extraction by 1 ml 
Con A-Sepharose 
0.5 0.8 0.12 0.6 4.2 >10 2.8 
/ j U T S H / m l 
20r 
14 
i I 
; ! 
J" i 
rf ': ! 
O-O 0. 0 
" B I G " - T 5 H * ' TSH % \ 
/ 
/ 
\ 
-Vi--J>*iatt.-tqjS>«^:o=io^rt^ 
24 28 32 36 40 
3.1 ml 
44 48 
F r a 
52 
c t i 
56 
o n 
64 68 72 76 80 
Fig. 6. 
Chromatograms of crude "big"-TSH on Sephadex G-100 after various treatments. 
(127 x 1.7 cm: buffer C; 4°C). 
1) • • • ( > • • Untreated. 
2) • 1 h; 37°C; 0.25 °/o Triton X 100; pH 7.4. 
3) • 1 h; 37°C; 0.25 Vo Triton X 100; 6 mol/1 guanidine-HCl; pH 5.1. 
The first peak represents "big"-TSH, the second peak regular TSH, the third peak, 
only seen on the guadinine-treated material, has not fully been investigated, but pos-
sibly contains ß-TSH, which shows almost the same binding characteristics with the 
antibody as the TSH-standard used in the assay. 
and 2-10-fold when compared with H L H . In this step the yield of "big"-TSH 
dropped from 100 to between 15 and 30 % . 
Further purification was achieved on Con A-Sepharose, the protein con-
centration then being below the limit of detection ( < 50 jug protein/ml). As 
compared with H G H this procedure resulted in a further 5-10-fold purifica-
tion. However, compared to H L H no further purification was achieved. The 
yield of "big"-TSH dropped by an additional factor of about 5. 
Table 1 shows the results of one experiment, where the purification of 
"big"-TSH was approximately 100-fold as compared to somatotrophin. 
Stability of "big"-TSH 
In an attempt to convert "big"-TSH to regular T S H and to find some in-
dications concerning the structure of "big"-TSH, the product was treated with 
6 mol/1 guanidine, 1 % mercaptoethanol and trypsin, respectively. 
Treatment with 6 mol/1 guanidine for 1 h at 37°C in the presence of 0.25 % 
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T S H / m l 
I i i i i i I 
10 H 18 2 2 2 6 3 0 3L 
1.5 m l F R A C T I O N S 
Fig. 7. 
Chromatograms of T S H and "big"-TSH on Sephadex G - 1 0 0 after treatment 
with mercaptoethanol. (70 x 1.1 cm; buffer C; 4°C). 
B HTSH (M. R. C. 68/38) untreated. 
• "big"-TSH untreated. 
© — "big"-TSH in buffer B; 1 h; 37°C; 1 °/o mercaptoethanol, pH 7.4. 
O " b i g " - T S H 66 h; 4°G; 1 °/o mercaptoethanol, pH 7.4. 
of the detergent Triton X 100 at p H 5.1 resulted in only a minor degradation 
of about 10-15% in contrast to regular T S H , which was almost completely 
destroyed under the same conditions (Fig. 6). Triton X 100 alone had no sig-
nificant effect on "big"-TSH. Moreover, the guanidine-treated "big"-TSH did 
not lose its biological activity, as shown in the cytochemical bioassay (Fig. 3). 
Treatment with 1 % mercaptoethanol at 4 °C and at 3 7 ° C led to loss 
of the immunological activity of "big"-TSH and regular T S H at similar rates, 
so that an intermediate formation of regular T S H from "big"-TSH could not 
conclusively be shown by this experiment. At 37°C, both "big"-TSH and re-
gular T S H lost 90 % of their immunological activities in the radioimmunoassay. 
At 4°C, approximately 50 % was lost within 48 h. Re-chromatography of the 
mercaptoethanol-treated "big"-TSH showed only a minor peak in the region 
where regular T S H would be expected (Fig. 7). 
709 
The digestion experiments with trypsin were performed in a mild procedure 
at p H 7.4 in the absence of calcium. Re-chromatography of the digestion mix-
ture on Sephadex G-200 demonstrated the formation of still immunologically 
active cleavage products, which were eluted between "big"-TSH and regular 
T S H , indicating molecular weights between "big"- and "regular" T S H . There 
was practically no products formed which could be eluted in the volume where 
T S H should appear (Fig. 2). 
So far none of the cleavage experiments have succeeded in the formation 
of regular T S H from "big"-TSH. 
D I S C U S S I O N 
High-molecular forms of H T S H have not been observed earlier probably be-
cause of the minute amounts found in the supernatant of pituitary homogenates, 
and because of the necessity of using long columns to separate "big" from re-
gular T S H . Additionally, the "big"-TSH-fractions obtained after chromato-
graphy on Sephadex G-100 columns are not homogeneous. On Sephadex G-200, 
turbid fractions can again be obtained, in which T S H is probably still linked 
to cell-fragments ("void volume-TSH"). The second fraction, which was 
eluted on G-200 between the void volume T S H and regular T S H , differs 
mainly in three aspects from regular T S H : 
Firstly, it showed a molecular weight of about 7 times that of regular T S H 
by chromatographic comparison with bovine catalase, secondly, in contrast to 
regular T S H , "big"-TSH was not cleaved into subunits by 6 mol/1 guanidine, 
and finally, it migrated faster on P A G E p H 7.5 when compared with highly 
purified T S H in spite of its much bigger molecular weight. 
This indicates more negatively charged groups, which could for instance 
be sialic acid groups. As tested by fluorescence with the ethidium bromide 
method, "big"-TSH contains no D N A or R N A in significant amounts. 
However, "big"-TSH also displays a series of features very similar to re-
gular T S H which do not exclude a relationship to regular T S H . Firstly it 
showed parallelism of its dilutions when compared with standard T S H in the 
radioimmunoassay, indicating identity of the antigenic sites and good acces-
sibility for the specific antibody, so that the antigenic site does not seem to be 
folded into the big protein. Moreover, "big"-TSH was bound to Con A -
Sepharose like glycoproteins just as regular T S H and could be displaced 
readily by a-methyl-D-mannoside. These features make it very likely that 
"big"-TSH contains, in some still unknown manner, regular T S H . The high 
stability against 6 mol/1 guanidine is surprising, but is in accordance with 
the high stability of "big"-LH as described by Prentice 8c Ryan (1975). This 
suggests, that "big"-TSH is not a mere aggregate but a covalently iinked pro-
duct, and indicates in addition, that the subunits in this "big"-TSH may also 
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be covalently linked, in contrast to those of regular T S H , which are easily 
cleaved by 6 mol/1 guanidine. 
W e still do not know, if "big"-TSH is a product, in which regular T S H 
is linked to a second "big"-protein or whether "big"-TSH is a covalently 
linked polymer of regular T S H . The latter possibility could be clarified, when 
sufficient amount of purified "big"-TSH has been prepared for the determina-
tion of its specific activity. Our attempts to cleave "big"-TSH with mercapto-
ethanol showed only, that the immunological activity was destroyed in the 
same way as that of regular T S H under these conditions. From these experi-
ments, we are therefore not able to elucidate on the combining groups in the 
"big"-TSH. But at the same time we cannot exclude, that disulphide groups 
play a role in binding. 
Our attempts to cleave "big"-TSH by tryptic digestion did not result in 
the production of regular T S H . This is in contrast to "b ig"-ACTH, which is 
transformed to regular A C T H by trypsin as described by Yalow (1974). But 
at least tryptic digestion products were formed, which still showed immuno-
logical activity in the radioimmunoassay and which on re-chromatography on 
Sephadex G-200 displayed molecular weights between "big"-TSH and re-
gular T S H . 
Interestingly, regular T S H , as well as "big"-TSH, guanidine-treated "big"-TSH 
and void volume T S H , showed biological activity in the cytochemical bioassay 
in good agreement with the radioimmunological findings. This allows the 
suggestion that in "big"-TSH as in void volume T S H the immunologically/ 
biologically active sites are accessible to the TSH-receptors of thyroid cells. 
The question of the amount of alpha and beta subunits in the "big"-TSH 
molecule can only be answered when firstly, "big"-TSH has been further 
purified, mainly using affinity chromatographic techniques with Con A -
Sepharose and solid-phase-anti-TSH, and secondly, when a mild cleavage 
procedure has been found. Attempts to determine the amount of alpha and 
beta subunits included in the "big"-TSH, based on measurements in poorly 
purified Sephadex eluates, are not valid because of the cross-reaction of the 
accompanying glycoproteohormones and their subunits which complicate the 
quantitation. 
In a few experiments, where serum of hypothyroid patients was chromato-
graphed on Sephadex G-100 or 200 no TSH-activity was found at the posi-
tion, where "big"-TSH should appear, even with a very sensitive radio-
immunoassay (limit of detection 0.1 /^U/ml). Interestingly Golslein-Golaire Sc 
Vanhaelst (1975) and Kourides et ah (1976) reported beta-TSH-subunit-ac-
tivity in some hypothyroid sera, corresponding to a "big"-beta-TSH with a 
molecular weight of approximately 160 000. It is still not known whether there 
is any relationship between the "big"-beta-TSH found occasionally in serum 
and "big"-TSH regularly present in pituitaries. 
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The physiological significance of "big"-TSH is still obscure and open to 
speculation. Up to date, it cannot be excluded that "big"-TSH is merely a 
side-product or an oxidation product of no physiological importance. If "big"-
T S H has any physiological significance, then we rather believe, because of the 
minute amounts present, that it is an intermediate between an even larger pre-
cursor and regular T S H , rather than a storage form, as has been suggested 
by Golstein-Golaire Sc Vanhaelst (1976). The "intermediate" hypothesis can, 
however, only be proven when we succeed in showing the formation and the 
disappearance of "big"-TSH in pituitary cells. 
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